Login
Toggle navigation
Videos
Categories
Trending
Stephanie Sirota is a partner at RTW Investments, while Jensen Huang is the founder and CEO of NVIDIA, and a Stanford graduate.
00:10:00
Watch Full Video
×
Please Login to watch Full video
Login
+ ADD TO Wishlist
×
Please login
Login
Share On Facebook
Share On Twitter
Peter is a partner and the president of RTW.
Recent Videos
00:17:08
Urasar is 100% Hayasa Metals Inc. owned; our exploration license over the Urasar mineral district
00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold 1
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio
Suggestions
00:00:00
Dr. Vishal Swaminathan - Residency at Mayo Clinic
00:10:00
WilmerHale at Entrepreneurship@Cornell: Annual 2-Day Conference Highlights
00:10:00
Rabobank's Robust Financial Results and Sustainability Initiatives | Wiebe Draijer, CEO, Rabobank.
00:10:00
How Quiet Luxury Can Elevate Your Social Media Presence
00:10:00
Allegion Chairman, President, and CEO Dave Petratis has been named a “CEO Who Gets It” by the National Safety Council.|John Stone is president and chief executive officer (CEO) for Allegion, as well as a member of the company’s Board of Directors.
00:10:00
Investment Opportunities in the Canadian EV and Lithium Industry: Development, Exploration, and Downstream Potential
00:10:00
serve the worlds most extraordinary people who are building tomorrows companies today|Justin Overdorff,Partner,Lightspeed Venture Partners
00:10:00
Building Impactful Companies|Scott Sandell,Partner,New Enterprise Associates (NEA)
00:10:00
Designing Our Dream World: How to Build the Future We Deserve|Andrew Beebe,Managing Director,Obvious Ventures
00:10:00
Reduce Your Tax Bill with Tax-Loss Harvesting: 4 Key Steps | Erik Herstad - Wealth Manager at Credent Wealth Management
00:10:00
Debate on Snapchat's Valuation: Innovation, Revenue, and Competition
00:10:00
After his first 100 days as BKW CEO, Robert Itschner answered questions from the media, revealing key insights in a video.